An Inside Look: The science behind Nu-V3
A detailed review of the science behind Nu-V3 and the Nu-V3 programs, how Nu-V3 delivers the treatment safely through neuromodulation and the unique manner in which the technology works, non-invasively, non-pharmaceutically with no negative side effects.
On the Radar: Future uses and patient populations
While Nu-Life is launching Nu-V3 for the treatment of pain, anxiety, depression and sleeplessness, the additional benefits of the Nu-V3 treatment are significant and will offer numerous opportunities to add uses for Nu-V3 and allow us to serve a wide variety of new patient populations.
Follow and collaborate on new uses and patient populations.
Research: Mechanisms of Actions Behind Nu-V3
There are three major elements or mechanisms of action that form the foundation of the Nu-V3 treatment. Vasodilation (increased blood flow), enkephalin production and cranial (vagal) electrical stimulation are the major actions which allow Nu-V3 to offer short and long term relief.
Follow and join our research on Nu-V3's mechanisms of action and advancements in our knowledge base.
In the Pipeline: New tech and product development
While Nu-V3 is a revolutionary technology, the Nu-Life team is constantly researching and updating our technology as well as utilizing and developing supportive technology such as HRV (heart rate variability), which allows us to extend the efficacy and effectiveness of the Nu-V3 treatment program.
Opportunity to Participate Financially: Share in our success
Open only to Medical Alliance members is our Medical Alliance Royalty Program. An option for Medical Alliance members to invest with Nu-Life and share in the profits through royalties on Nu-V3 devices sold globally.
Review the details of the Medical Alliance Royalty Program